IPP Bureau
Mylab appoints Rajesh Patel as the Executive Director of In-Vitro Diagnostics Business
By IPP Bureau - May 09, 2022
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Premas Biotech appoints Saumen Chakraborty to its Board
By IPP Bureau - May 09, 2022
Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad
Aadi Bioscience announces collaborations with next generation sequencing leaders
By IPP Bureau - May 09, 2022
The company enters into collaborations with leading next-generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial
Lupin selects HPE GreenLake edge-to-cloud platform
By IPP Bureau - May 09, 2022
Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss
Challenges of Thalassemia management in India bring like-minded stakeholders together
By IPP Bureau - May 08, 2022
Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India
Thalassemia children require comprehensive treatment approach: Dr Sunil Bhat, Narayana Health City
By IPP Bureau - May 08, 2022
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
Novavax submits variations to expand approval in Australia and New Zealand for adolescents
By IPP Bureau - May 08, 2022
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
Oncocyte completes validation of Therasure transplant monitor test
By IPP Bureau - May 08, 2022
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Quality issues force Novartis to suspend production of radioligand therapy medicines
By IPP Bureau - May 08, 2022
The production suspension impacts commercial and clinical trial supply
Lonza to sell processing plant in Quakertown, Pennsylvania
By IPP Bureau - May 08, 2022
Upon closing, the Quakertown business will become an independent company called Microsize
Department of Pharmaceuticals releases Guidelines on Pharmaceutical Innovation
By IPP Bureau - May 07, 2022
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
SKS Hospital, Salem installs Carestream’s detector for paediatric studies
By IPP Bureau - May 07, 2022
This newly designed small-format detector is made up of caesium iodide technology and is extremely high in resolution, capable of capturing the fine detail of smaller anatomical structures present in paediatric patients
Biotium acquires CAT5 RNA/DNA extraction technology from Cell Data Sciences
By IPP Bureau - May 07, 2022
RNAstorm and DNAstorm RNA/DNA extraction kits will be sold exclusively through the Biotium website and authorized distributors
Gut microbiome as a tool in regenerative medicine
By IPP Bureau - May 07, 2022
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Biogen and MedRhythms partner for digital therapeutic targeting the treatment of gait deficits in multiple sclerosis
By IPP Bureau - May 06, 2022
The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation (RAS)
